U.S. authorities due to make arrests in futures ‘spoofing’ probe: sources
WASHINGTON (Reuters) – U.S. authorities were set to arrest several people on Monday in connection with a federal investigation into so-called spoofing and manipulation in the U.S. futures market by three European banks, three people with direct knowled…
VW supervisory board demands inquiry into diesel fume tests
FRANKFURT (Reuters) – Volkswagen’s supervisory board called on Monday for an immediate inquiry into who ordered scientific tests in which monkeys were exposed to toxic diesel fumes, while the German government said such studies were unjustifiable.
Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom
PARIS/LONDON (Reuters) – French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.
Apple set to halve first quarter iPhone X production target: Nikkei
(Reuters) – Apple Inc has notified suppliers that it will halve its iPhone X production target for the first quarter to around 20 million units, Nikkei reported on Monday without citing a source.
Tech stocks reach record, bond yields rise again
LONDON (Reuters) – Technology stocks rallied on Monday at the start of a big week of earnings for the sector globally, while bond yields hit multi-year highs as investors braced for major central banks to step back from ultra-easy monetary policies.
Private equity firm KKR names French businessman Veyrat as senior adviser
PARIS (Reuters) – Investment and private equity firm KKR has named Jacques Veyrat, a well-known businessman with previous leading positions in the commodities and telecoms sectors, as senior adviser in France as KKR looks to build its presence in the …
Sanofi buys Ablynx for $4.8 billion in biotech M&A boom
PARIS/LONDON (Reuters) – French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.
VW supervisory board members demand inquiry into diesel fume tests on monkeys
FRANKFURT (Reuters) – Members of Volkswagen’s supervisory board have called for an inquiry into tests in which monkeys were exposed to toxic diesel fumes, German media reported on Monday.
France’s Sanofi buys Ablynx for $4.8 billion in biotech M&A boom
PARIS/LONDON (Reuters) – French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.
KPMG’s audits of Carillion to be investigated: UK watchdog
LONDON (Reuters) – Britain’s Financial Reporting Council (FRC) has opened an investigation into KPMG’s auditing of the now-collapsed Carillion covering the years 2014 to 2017, the watchdog said on Monday.
